Omeprazole, one of the most widely used medications in the world, is generally well tolerated in the short term, with the most frequently reported side effects being diarrhea, headache, flatulence, abdominal pain, and constipation. These everyday complaints tend to be mild and often resolve on their own. The picture gets more interesting with long-term use, where a different set of concerns emerges involving nutrient absorption, gut bacteria, bone strength, kidney health, and a handful of rarer but more serious possibilities that are still being studied.
Common Short-Term Side Effects
If you take omeprazole for a few weeks to treat heartburn or an ulcer, the side effects you might notice are the same garden-variety digestive complaints you could get from many medications. Clinical trials consistently report diarrhea, headache, dizziness, flatulence, abdominal pain, and constipation as the most common adverse events.1PubMed. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs The rate of serious adverse events in short-term trials has been comparable to placebo and to older acid-reducing drugs, with no specific pattern of symptoms unique to omeprazole.2PubMed. The clinical safety of omeprazole Nausea crops up occasionally too, though most people taking a standard course never feel much of anything beyond their symptoms improving.
For the millions of people prescribed a short course after an endoscopy or during treatment for a stomach infection, these side effects are the beginning and end of the story. The concerns that make headlines are almost entirely about what happens when you stay on the drug for months or years.
How Omeprazole Reshapes Your Gut
Stomach acid does more than digest food. It also kills many of the bacteria you swallow throughout the day. When omeprazole dramatically lowers that acidity, more bacteria survive the trip into your intestines. Studies have found measurable shifts in the gut microbiome after omeprazole treatment, with changes in the types and diversity of bacteria living in the colon.3PubMed Central. Effects of proton pump inhibitor on the human gut microbiome profile in multi-ethnic groups in Singapore Higher doses seem to push these changes further, with some tendency toward reduced diversity at higher omeprazole doses compared to lower ones.4PubMed. The effect of omeprazole treatment on the gut microflora and neutrophil function
One practical consequence is an increased risk of Clostridioides difficile infection, a potentially serious gut infection that causes severe diarrhea. Research using bioreactor models suggests this happens primarily because the altered pH in the gastrointestinal tract creates a more hospitable environment for C. difficile spores, rather than through a direct drug-microbiome interaction.5PubMed Central. Proton-pump inhibitors increase C. difficile infection risk by altering pH rather than by affecting the gut microbiome based on a bioreactor model
A related concern is small intestinal bacterial overgrowth, or SIBO, where bacteria proliferate in parts of the gut where they normally do not thrive. Two separate meta-analyses have found that people taking proton pump inhibitors face a moderately higher risk of SIBO, with odds roughly 1.7 to 2.3 times those of non-users depending on the analysis.6PubMed. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth7Clinical Gastroenterology and Hepatology. Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis SIBO can cause bloating, gas, and diarrhea that might easily be mistaken for the digestive side effects of the drug itself, which makes it worth flagging to your doctor if those symptoms are persistent.
Nutrient Absorption Problems
Stomach acid plays a key role in freeing certain nutrients from food so your body can absorb them. Suppress that acid for long enough, and deficiencies can develop in several important areas.
- Vitamin B12: Omeprazole reduces the absorption of B12 by preventing its release from dietary proteins. Over time, this can lead to B12 deficiency, which may cause fatigue, neurological symptoms like tingling or numbness, and anemia.8PubMed. Omeprazole and vitamin B12 deficiency
- Magnesium: Low magnesium has been recognized as a side effect of proton pump inhibitors. The drug appears to impair the gastrointestinal absorption of magnesium, and in severe cases the resulting deficiency can cause muscle cramps, irregular heart rhythms, and even seizures.9PubMed Central. Proton pump inhibitor-induced hypomagnesemia: A new challenge.
- Iron: Gastric acid helps convert dietary iron into a form your gut can absorb. Long-term omeprazole use has been linked to iron deficiency anemia, with case reports documenting this in patients who had been on the drug for many years.10PubMed Central. Iron Deficiency Anemia Due to the Long-term Use of a Proton Pump Inhibitor.
These deficiencies do not develop overnight. They are primarily a concern for people taking omeprazole continuously for many months or years, and they are usually caught with routine blood work. If you are on long-term omeprazole, periodic checks of B12, magnesium, and iron levels are a reasonable precaution.
Bone Health and Fracture Risk
Calcium absorption also depends partly on an acidic stomach environment, which has raised questions about whether long-term omeprazole use weakens bones. Observational evidence points in a concerning direction. A narrative review of the literature found substantial evidence linking long-term proton pump inhibitor use to an increased risk of fractures at the hip, spine, and wrist.11PubMed Central. Proton Pump Inhibitors and Bone Health: An Update Narrative Review
One study of postmenopausal women found that omeprazole users had a vertebral fracture rate roughly three times higher than non-users after adjusting for other risk factors.12PubMed. Increase in vertebral fracture risk in postmenopausal women using omeprazole That is a single study in a specific population, so the exact magnitude should be taken cautiously, but the overall pattern across multiple studies is consistent enough that the FDA added a fracture warning to proton pump inhibitor labels years ago. If you already have risk factors for osteoporosis, this is worth discussing with your doctor before committing to years of omeprazole.
Kidney Effects
Acute interstitial nephritis is an inflammatory kidney condition that is uncommon but well documented with omeprazole. The drug is recognized as an important cause of this type of kidney injury, and dozens of cases have been reported in the medical literature.13PubMed. Acute interstitial nephritis due to omeprazole14PubMed. Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury? The reaction appears to be an immune-mediated process rather than a dose-dependent toxicity, meaning it can happen at standard doses and is not always predictable.
In one reported case, a patient developed kidney inflammation after starting omeprazole at a routine dose following surgery. Even after stopping the drug and receiving steroid treatment, permanent kidney damage resulted, leaving him with an elevated baseline creatinine level.15PubMed Central. A Case of Omeprazole-Associated Acute Interstitial Nephritis Cases like this are rare, but they underline that omeprazole is not completely benign. Unexplained nausea, fatigue, or changes in urine output while on the drug warrant prompt medical attention.
Stomach Polyps
Long-term omeprazole use is associated with the development of fundic gland polyps, small growths that form in the upper part of the stomach lining. A meta-analysis of twelve studies found that proton pump inhibitor users were about two and a half times more likely to have these polyps than non-users. The risk climbed with duration: people who had been on the drugs for at least a year were over five times more likely to develop them.16PubMed. Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors17PubMed. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis Another study found that the single strongest predictor of these polyps was proton pump inhibitor use lasting more than four years.18PubMed. Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps
The reassuring news is that fundic gland polyps are almost always benign. They rarely cause symptoms, are typically found incidentally during an endoscopy, and often regress after the drug is stopped. They are not considered a prelude to stomach cancer. Still, their presence is a visible marker that the medication is altering the stomach lining, and they serve as a reminder that the drug’s effects go beyond acid suppression.
Pneumonia Risk
The same “acid wall” that protects your gut from swallowed bacteria also provides some defense against respiratory infections. When stomach acid drops, bacteria from the mouth can colonize the upper gastrointestinal tract, and some of these organisms can be aspirated into the lungs.19JAMA. Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs Population-based studies have found a link between proton pump inhibitor use and community-acquired pneumonia, with the strongest association appearing shortly after starting the drug.20JAMA Internal Medicine. Use of Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: A Population-Based Case-Control Study This risk has also been studied specifically in people with diabetes, where the combination of immune changes and acid suppression may compound the problem.21PubMed Central. Association of Increased Risk of Pneumonia and Using Proton Pump Inhibitors in Patients With Type II Diabetes Mellitus
The absolute increase in pneumonia risk is modest for most people, but it adds to the case for not staying on omeprazole indefinitely when the original reason for taking it has resolved.
The Clopidogrel Interaction
If you take the blood thinner clopidogrel, omeprazole deserves special caution. Clopidogrel is a prodrug, meaning your body has to convert it into its active form using a liver enzyme called CYP2C19. Omeprazole inhibits that same enzyme, which can reduce the blood-thinning effect of clopidogrel. Among the various proton pump inhibitors, omeprazole is a particularly potent inhibitor of CYP2C19.22Scientific Reports. Effects of treatment with clopidogrel with or without proton pump inhibitor omeprazole on the risk of ischemic stroke: a nationwide cohort study Lab studies confirm that omeprazole can measurably reduce clopidogrel’s antiplatelet activity.23PubMed Central. Clinical relevance of clopidogrel-proton pump inhibitors interaction
For people who need both an acid reducer and clopidogrel, doctors often recommend switching to a different proton pump inhibitor with weaker CYP2C19 inhibition, or using a different class of acid-reducing medication altogether. This is one of the more concrete and actionable drug interactions to be aware of.
Dementia and Cognitive Concerns
Headlines linking proton pump inhibitors to dementia have generated significant anxiety among long-term users. The evidence behind them, though, is genuinely mixed. Several observational studies have found a statistical link between prolonged PPI use and cognitive decline or dementia in older adults.24PubMed Central. Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks But the results across studies are inconsistent. Some have found an increased risk, while at least one case-control study actually reported a decreased risk of dementia among PPI users.25PubMed Central. Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences
Observational studies are particularly tricky here. People who take PPIs long-term often have other health conditions, take multiple medications, and may differ in many ways from non-users. Untangling whether the drug itself is doing something to the brain or whether it is simply a marker for other risk factors has proven difficult. No randomized trial has established a causal connection, and the absence of a clear link in some well-designed studies suggests the relationship, if it exists at all, is not straightforward. This does not mean the concern is baseless, but it is far from settled.
Cardiovascular Questions
Some researchers have explored whether omeprazole might increase cardiovascular risk through effects on blood vessel function. One proposed mechanism involves an enzyme called DDAH1; the theory was that omeprazole might inhibit this enzyme and lead to accumulation of a molecule that impairs nitric oxide production, which is important for healthy blood vessels. However, a study testing this in a real population found that at clinical doses, PPIs are weak inhibitors of DDAH1, and PPI use was not significantly associated with the relevant marker in participants.26PubMed Central. Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
Separately, animal and lab research has suggested omeprazole can impair vascular function through oxidative stress pathways.27PubMed Central. Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction Whether this translates into meaningful heart disease risk in humans remains unclear. Much of the cardiovascular concern around PPIs has been entangled with the clopidogrel interaction described earlier, making it hard to isolate an independent cardiac effect. The current state of the evidence does not strongly support avoiding omeprazole for cardiovascular reasons alone, but it adds another reason to use the lowest effective dose for the shortest necessary time.
Rebound Acid When You Stop
One side effect that surprises many people is what happens after they stop taking omeprazole. Prolonged use causes the stomach to compensate by producing more of the hormone gastrin, which stimulates acid-producing cells. When you abruptly stop the drug, those extra cells keep working, and you can temporarily produce more acid than you did before you started. This “rebound” can cause a flare of heartburn or reflux that feels worse than the original problem, which understandably makes some people think they still need the medication.28PubMed. Strategies for Effective Discontinuation of Proton Pump Inhibitors
Rebound symptoms are temporary, but they can last several weeks. The standard approach to avoid them is a gradual taper: stepping down the dose over a period of weeks, sometimes switching to an every-other-day schedule or using an antacid to manage symptoms during the transition. If you have been on omeprazole for more than a few weeks, stopping cold turkey is not recommended without checking with your prescriber.
Rare Skin and Autoimmune Reactions
Case reports have documented omeprazole triggering subacute cutaneous lupus erythematosus, an autoimmune skin condition that causes red, scaly patches, often in sun-exposed areas.29PubMed Central. Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus Drug-induced lupus is not unique to omeprazole; many medications can trigger it. But it is worth recognizing because the rash may appear weeks to months after starting the drug, making it easy to miss the connection. The condition typically resolves after stopping the medication, though some patients need additional treatment to clear the skin findings.
Other skin reactions like rash and itching can occur with omeprazole, as they can with most medications. Severe allergic reactions are exceedingly rare. If you develop widespread hives, swelling, or difficulty breathing, that warrants emergency care regardless of whether you suspect the drug.